- Report
- May 2025
- 194 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- July 2025
- 179 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Clinical Trials
- April 2025
- 65 Pages
Global
From €1316EUR$1,500USD£1,139GBP
- Report
- August 2024
- 184 Pages
Global
From €2194EUR$2,500USD£1,898GBP
- Report
- May 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- March 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- July 2025
- 183 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- June 2025
- 400 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1316EUR$1,500USD£1,139GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1755EUR$2,000USD£1,519GBP
- Report
- May 2025
- 182 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- May 2025
- 185 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- May 2025
- 180 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- April 2025
Global
From €4300EUR$4,900USD£3,721GBP
- Report
- June 2025
- 100 Pages
Global
From €4300EUR$4,900USD£3,721GBP
- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- November 2024
- 150 Pages
Global
From €2852EUR$3,250USD£2,468GBP
€4256EUR$4,850USD£3,683GBP

The antiemetic market within the context of gastrointestinal drugs is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat nausea and vomiting. These drugs are used to treat a variety of conditions, including motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Antiemetics are also used to treat nausea and vomiting caused by certain medications, such as opioids.
The antiemetic market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, Sanofi, and Takeda Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla, also offer antiemetic products. Show Less Read more